ISPOR Europe 2021

 November 30- December 3, 2021| Virtual
Published on:
November 24, 2021

Alira Health recently attended the Virtual ISPOR Europe 2021, the leading global conference for Health Economics and Outcomes Research (HEOR) November 30- December 3 for a virtual discussion and dissemination of the latest trends in healthcare.

Meet the Team Attending

Richard Charter, VP, Market Access,  MedTech, Europe and Asia Pacific
Elodie Lehmann Manager, Market Access, France
Romain Finas, VP, Real-World Evidence
Nerea Blanqué-Catalina VP, Global Market Access
Andrea Mantovani, VP, Global Market Access
Annabel De Maria, VP, Patient Engagement
Catia Proenca, Director, Global Market Access
Ahmad Bechara, VP, Global Pricing & Market Access

Related news

News September 8, 2023
Alira Health Partners With Col·legi de Metges de Barcelona
We are pleased to partner with Col·legi de Metges de Barcelona (CoMB), an institution that represents and serves the almost 39,000 physicians in Barcelona.
Market Access Spain Startups
Events August 10, 2023
12th EPP Life Sciences Pricing Forum
We are excited to speak at the 12th EPP Life Sciences Pricing Forum for pricing directors and executives in Life Sciences.
EU Market Access
Events July 31, 2023
ESMO Congress
We are excited to join the ESMO Congress in Madrid. to disseminate the latest cutting-edge data for oncologists and other stakeholders.
Drug Development Market Access Oncology Spain
Publications July 25, 2023
Improving Access to Medicine: The Role of Pharma Companies in Emerging Markets
Our Market Access experts have identified risks and opportunities associated with improving access to medicines in emerging countries.
Market Access Pharma
Blog June 30, 2023
Why You Need Market Access and How to Get Started
Start reading to learn about the importance of market access in pharma and MedTech and the key steps to get started.
Market Access MedTech Pharma
Blog April 17, 2023
Reimbursement of Rare Disease Drugs in Italy: Challenges and Hopes for the Future
When it comes to rare diseases, Italy has done a good job in bringing EMA-approved drugs, including orphan drugs, to the Italian market. But  multiple challenges exist, many of which(...)
Italy Market Access Pharma Rare Disease Real-World Evidence (RWE)
Blog April 17, 2023
Pharmaceutical Market Access in the UK: A Changing Landscape
Start reading this interview with Rachel Fyson to gain insight into the changing landscape of market access in the United Kingdom.
Market Access Pharma UK
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.